ICN Pharmaceuticals Inc. has again extended its offer to buy drug-maker Ribapharm Inc. until 1 August 2003 and emphasized that shareholders should not expect its $168 million bid to be sweetened. As of July 29, when the offer was set to expire, about 7.7 million Ribapharm shares were tendered for the offer of $5.60 a Read more about ICN Extends Ribapharm Offer, Says No Sweetener[…]